Kenneth Grise
Principal, Healthcare Investments at Sixty Degree Capital
Toronto, Ontario
Overview
Work Experience
Principal, Healthcare Investments
2024 - Current
Associate, Healthcare Investments
2021 - 2024
• Invest into cutting-edge life sciences companies across any modality, indication, and geography • Examples of direct company investments include: Bionaut Labs, T-Knife Therapeutics, Turnstone Biologics, Transthera Biosciences, Korro Bio, Reflexion Medical, Everside Health, Nextpoint Therapeutics, Strive Health, Fog Pharma • Support companies on their mission to develop novel therapeutics, biotechnologies, and healthcare services • Invest into world-leading healthcare venture capital funds (5 fund investments to date) • Passionate supporter of biotech innovation ecosystems and entrepreneurs
Freelance Scientific Consultant
2013
I provide scientific consulting services to both the Biotechnology and Entertainment industries.
Investor
2024 - 2024
FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.
Raised $530,271,035.00 from venBio Partners, RA Capital Management, Google Ventures, Marshall Wace, Samsara BioCapital, SymBiosis, Nextech Invest, Catalio Capital Management, Fidelity and T. Rowe Price.
Investor
2023 - 2023
Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.
Raised $386,000,000.00 from Town Hall Ventures, New Enterprise Associates, Ascension Ventures, CapitalG, Echo Health Ventures, Redpoint and CVS Health Ventures.
Investor
2023 - 2023
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Raised $122,500,000.00 from Leaps by Bayer, Invus, Arkin Holdings, Gordon Freeman, WTT Investment, Binney Street Capital, Sixty Degree Capital, Sanofi Ventures, MPM Capital and Catalio Capital Management.
Scientific Consultant
2019 - 2023
• Currently consulting with Vivid Foundry in a scientific advisory role for their debut game "Solace State" (release date TBA). • I provide scientific and creative insight to the writing team toward developing realistic plot points and content based on scientific topics ranging from neuroscience and biotechnology to quantum physics.
Investor
2022 - 2022
Everside Health is a direct primary care provider offering convenient on-site, near-site, and virtual care for its members.
Raised $329,000,000.00 from Bossa Invest, Endeavor Catalyst, Alta Partners, Oak HC/FT, New Enterprise Associates, Greenspring Associates, New Enterprise Associates, Oak HC/FT and Alta Partners.
Investor
2022 - 2022
RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.
Raised $675,100,000.00 from Catalio Capital Management, T. Rowe Price, Venrock, The Rise Fund, Squarepoint Capital, Pictet Private Equity Investors S.A., Pfizer Venture Investments, Ally Bridge Group, Hillenbrand Capital Partners, LLC. and Johnson & Johnson Innovation – JJDC.
Investor
2022 - 2022
IPO
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Raised $277,500,000.00 from Tri Locum Partners, Deep Track Capital, Rock Springs Capital, Atlas Venture, New Enterprise Associates and Blue Owl.
Investor
2021 - 2021
Education
Doctor of Philosophy (Ph.D.)
2013 - 2020
Master of Science (M.Sc.)
2010 - 2012
Honours BSc
2004 - 2010